1st People's Hospital of Foshan Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00615667
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Department of Nephrology, 1st People's Hospital of Foshan

Active Ingredients

Drugs in Phase 3 Trials (3)

azathioprine (imuran) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

tacrolimus (prograf) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Kidney Diseases (Phase 3)

Lupus Nephritis (Phase 3)

Nephritis (Phase 3)

Nephrosis (Phase 3)

Nephrotic Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3